Old Mission Capital LLC Alterity Therapeutics LTD Transaction History

Old Mission Capital LLC

  • $4.27 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$0.3 - $4.9 $10,827 - $176,855
36,093 New
36,093 $12,000
Q3 2019

Nov 14, 2019
SELL
$0.0 - $0.02 $0 - $254
-12,707 Closed
0 $0
Q2 2019

Aug 14, 2019
BUY
$0.0 - $0.03 $0 - $381
12,707 New
12,707 $17,000

Others Institutions Holding ATHE

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About ALTERITY THERAPEUTICS LTD

ATHE Quotes by TradingView
  • Ticker ATHE
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,114,600
  • Market Cap $86.2M
  • Description
  • Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. The company's lead drug candidate is ATH434 that has completed Phase I clinical trial for the treatment of Parkinson's disease. It is also...
More about ATHE
Track This Portfolio

Track Old Mission Capital LLC Portfolio

Follow Old Mission Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Old Mission Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Old Mission Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email